Golden State Equity Partners Gilead Sciences, Inc. Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 2,564 shares of GILD stock, worth $185,659. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,564
Previous 2,829
9.37%
Holding current value
$185,659
Previous $212,000
2.36%
% of portfolio
0.05%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
1,892Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.87 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.31 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$6.12 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.43 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.18 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $90.8B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...